Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1051 | 1000 | 1165 | 1007 | 1075 | 1282 |
Fund Return | 5.05% | -0.04% | 16.53% | 0.23% | 1.45% | 2.52% |
Place in category | 2812 | 2210 | 2767 | 1693 | - | - |
% in Category | 95 | 74 | 93 | 71 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bellevues Lux BB Adamant Medtech HB | 1.59B | 8.29 | -4.05 | 7.91 | ||
Adamant Medtech B EUR | 1.59B | 11.11 | 0.30 | 11.14 | ||
Adamant Medtech I EUR | 1.59B | 11.77 | 1.01 | 11.93 | ||
Adamant Medtech T EUR | 1.59B | 11.49 | 0.70 | 11.58 | ||
LU1477743386 | 387.32M | 5.31 | -2.53 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fuzge | 15.77B | 14.27 | 1.41 | 10.59 | ||
Capital Group New Perspective Fube | 15.77B | 13.60 | 0.67 | 9.71 | ||
Capital Group New Perspective Fubde | 15.77B | 13.59 | 0.65 | 9.71 | ||
Cap Group New Perspective lux N | 15.77B | 13.02 | 0.00 | - | ||
Cap Group New Perspective lux C EUR | 15.77B | 15.10 | 2.23 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Deutsche Boerse | DE0005810055 | 3.49 | 218.700 | +1.44% | |
Heineken | NL0000009165 | 3.22 | 70.12 | +0.57% | |
Samsung Electronics Co Pref | KR7005931001 | 3.14 | 47,450 | -3.16% | |
Reckitt Benckiser | GB00B24CGK77 | 3.08 | 4,939.0 | +0.76% | |
Roche Holding Participation | CH0012032048 | 3.01 | 252.50 | +0.44% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review